JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q3 2025 financial results
Johnson & Johnson (NYSE: JNJ) reported its third quarter 2025 earnings results today. Reported sales increased 6.8% year-over-year to $24 billion. Operational sales were up 5.4%. GAAP net earnings rose 91% to $5.2 billion, or $2.12 per share, compared to last year. Adjusted EPS grew 16% to $2.80. Revenue and earnings beat estimates. The company … Read more
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content